A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Clinical trial NCT07287995 · RECRUITING
Trial details
- NCT number
- NCT07287995
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-05
- Primary completion
- 2029-06-30
- Enrollment
- 428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.